Nu Skin Enterprises, Inc. (NUS)
NYSE • Consumer Defensive
Last close at September 10, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Nu Skin Enterprises, Inc. currently loses $78.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 55 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Nu Skin Enterprises said, based on preliminary results for the second fiscal quarter of 2026 reported on August 10, that adjusted EPS of $0.20 matched the $0.20 consensus, while revenue of about $320.1 million missed the $345.2 million estimate by 7.3%. Revenue fell roughly 17% from about $386.1 million a year ago, and gross profit came in at about $218.3 million with gross margin near 68%, keeping profitability tied to a lower top line. Operating cash flow was $10.6 million, and the company paid $2.9 million in dividends.
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. (NYSE: NUS) sells beauty, personal care, and nutritional products in the consumer household and personal care market, with $1.5 billion in FY2025 revenue. Its portfolio centers on the ageLOC and Pharmanex brands and spans skincare systems, cleansing devices, supplements, and weight-management offerings sold across international markets.
Today's Snapshot
NUS closed 0.6% above yesterday's close.
Trading Volume
Below 10d avg (544.4K)
504.8K
vs S&P 500 Today
Outperforming Market
+1.19%
Updated: September 10, 2026 at 20:23 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$4.80 - $7.32Sell
- RSI (14)50.21Neutral
- Stochastic %K (14, 3, 3)69.95Neutral
- MACD Level (12, 26)-0.07Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.